CEO Mark Capone explains what personalized medicine is and the role of genetics in tailoring and improving treatments for individual patients. “Historically, we would take a one-size-fits-all approach for all patients, but now, with personalized medicine, we can fundamentally change that approach.”

Myriad Genetics at J.P. Morgan Healthcare Conference

Paul J. Diaz, president and chief executive officer, Bryan Riggsbee, chief financial officer, and Dale Muzzey, chief scientific officer, presented at the 41st annual J.P. Morgan (JPM) Healthcare Conference.